Combining (preclinical) imaging and targeted therapy, is the basis of theranostics. In this webinar, Dr. Florea will highlight several studies performed at RWTH Aachen, where SPECT-CT non-invasive imaging was used to evaluate theranostic compounds.

fMRI studies often involve the electrical stimulation of i.e. the forepaw, detecting where this stimulation is registered in the brain via modifications in blood oxygen level dependent (BOLD) signal.

Because of their ability to kill tumour cells, NK cells are an attractive target in cancer immunotherapy, therapeutic monoclonal antibody development and adoptive cell therapies.

Preclinical imaging (PCI) plays a vital role in understanding the biological processes behind disease states at the organ, tissue, cell and molecular level. 

Aurora system with ESP option, can fully resolve particles around 70nm and from the 80nm PS bead. The new violet laser scatter enhancement option increases the sensitivity of size detection for biological particles down to 87.5nm.

Spectral Instrument Imaging just announced a new, strategic partnership with InVivo Analytics, which enables quantitative analysis of bioluminescent reporter distributions across different animals, entire cohorts and study time points.

By combining study design, study management, and image analytics in all major imaging modalities, BioLaurus has conducted critical preclinical and clinical stage drug development studies.